Bioinnovator Novozymes Upgrades to LABVANTAGE R5.2

LABVANTAGE today announces that Novozymes, globally renowned biotechnology company, upgrades its LABVANTAGE Laboratory Information Management System (LIMS) to improve quality management of their 700+ enzymes, biopharmaceuticals and microorganisms in 130 countries worldwide. This $1 million project will upgrade and further enhance the existing SAPPHIRE R4.4 to LABVANTAGE R5.2. This project will include the addition of the Reagents & Standards Management (RSM) and Advanced Storage & Logistics (ASL) modules.

Please to read the entire article.